clinical pharmacology
Pharmacoepidemiology and Pharmacovigilance
July 04 by Elie MagdalaniPharmacology is the study of the effects of drugs. The other interesting branch known as the “clinical pharmacology” is interested in the effects of drugs in humans by which therapy is individualised...
Challenges and Benefits of Patient-Based Phase I Trials
May 05 by Pharma IQPharma IQ held a Q&A session with Dr. James Dow, Director of Clinical Pharmacology & DMPK, (OSI) Prosidion to gain a few insights into phase I clinical development and patient-bas...
What Are the Advantages and Disadvantages of Human Embryonic Kidney (HEK) Cells for the Analysis of Uptake Transporters?
March 04 by Rebecca MaschkeDr. Jörg König from the Institute for Experimental and Clinical Pharmacology and Clinical Toxicology at Friedrich-Alexander-University Erlangen-Nürnberg, Germany, speaks to Rebecca Ma...
Best Practice Tips for Overcoming Obstacles in Biomarker Development
July 29 by Pharma IQHow can we overcome the latest challenges in Biomarker Development? Birgitte Søgaard, Divisional Director for Clinical Pharmacology and Translational Medicine at H Lundbeck A/S, discusses wit...
Fail Early in Clinical Development if You Want to Succeed
June 10 by Andrea CharlesIf you are going to fail, it is better to fail earlier. All phases of clinical research are striving to reduce attrition, streamline their processes and develop drugs cost-effectively.